nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—Dinoprostone—SLC51A—osteoporosis	0.0213	0.842	CrCbGaD
Lubiprostone—Dinoprostone—CYP19A1—osteoporosis	0.00401	0.158	CrCbGaD
Lubiprostone—Constipation—Calcitriol—osteoporosis	0.0016	0.00164	CcSEcCtD
Lubiprostone—Flatulence—Conjugated Estrogens—osteoporosis	0.00159	0.00163	CcSEcCtD
Lubiprostone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00158	0.00162	CcSEcCtD
Lubiprostone—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00158	0.00162	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Raloxifene—osteoporosis	0.00158	0.00162	CcSEcCtD
Lubiprostone—Diarrhoea—Etidronic acid—osteoporosis	0.00158	0.00162	CcSEcCtD
Lubiprostone—Abdominal pain—Estropipate—osteoporosis	0.00158	0.00162	CcSEcCtD
Lubiprostone—Feeling abnormal—Ibandronate—osteoporosis	0.00157	0.00162	CcSEcCtD
Lubiprostone—Tremor—Zoledronate—osteoporosis	0.00157	0.00161	CcSEcCtD
Lubiprostone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00157	0.00161	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Ibandronate—osteoporosis	0.00156	0.0016	CcSEcCtD
Lubiprostone—Myalgia—Pamidronate—osteoporosis	0.00156	0.0016	CcSEcCtD
Lubiprostone—Anxiety—Pamidronate—osteoporosis	0.00156	0.0016	CcSEcCtD
Lubiprostone—Ill-defined disorder—Zoledronate—osteoporosis	0.00155	0.00159	CcSEcCtD
Lubiprostone—Abdominal pain—Alendronate—osteoporosis	0.00155	0.00159	CcSEcCtD
Lubiprostone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00155	0.00159	CcSEcCtD
Lubiprostone—Shock—Risedronate—osteoporosis	0.00155	0.00159	CcSEcCtD
Lubiprostone—Nervous system disorder—Risedronate—osteoporosis	0.00154	0.00158	CcSEcCtD
Lubiprostone—Discomfort—Pamidronate—osteoporosis	0.00154	0.00158	CcSEcCtD
Lubiprostone—Skin disorder—Risedronate—osteoporosis	0.00153	0.00157	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Calcitriol—osteoporosis	0.00153	0.00157	CcSEcCtD
Lubiprostone—Abdominal pain—Raloxifene—osteoporosis	0.00153	0.00157	CcSEcCtD
Lubiprostone—Malaise—Zoledronate—osteoporosis	0.00151	0.00155	CcSEcCtD
Lubiprostone—Abdominal pain—Ibandronate—osteoporosis	0.00151	0.00155	CcSEcCtD
Lubiprostone—Syncope—Zoledronate—osteoporosis	0.0015	0.00154	CcSEcCtD
Lubiprostone—Oedema—Pamidronate—osteoporosis	0.0015	0.00154	CcSEcCtD
Lubiprostone—Palpitations—Zoledronate—osteoporosis	0.00148	0.00152	CcSEcCtD
Lubiprostone—Abdominal pain—Calcitriol—osteoporosis	0.00148	0.00152	CcSEcCtD
Lubiprostone—Shock—Pamidronate—osteoporosis	0.00147	0.00151	CcSEcCtD
Lubiprostone—Loss of consciousness—Zoledronate—osteoporosis	0.00147	0.00151	CcSEcCtD
Lubiprostone—Hypersensitivity—Estropipate—osteoporosis	0.00147	0.00151	CcSEcCtD
Lubiprostone—Nervous system disorder—Pamidronate—osteoporosis	0.00147	0.00151	CcSEcCtD
Lubiprostone—Vomiting—Etidronic acid—osteoporosis	0.00146	0.0015	CcSEcCtD
Lubiprostone—Cough—Zoledronate—osteoporosis	0.00146	0.0015	CcSEcCtD
Lubiprostone—Oedema peripheral—Estradiol—osteoporosis	0.00146	0.0015	CcSEcCtD
Lubiprostone—Tachycardia—Pamidronate—osteoporosis	0.00146	0.0015	CcSEcCtD
Lubiprostone—Connective tissue disorder—Estradiol—osteoporosis	0.00146	0.0015	CcSEcCtD
Lubiprostone—Rash—Etidronic acid—osteoporosis	0.00145	0.00149	CcSEcCtD
Lubiprostone—Dermatitis—Etidronic acid—osteoporosis	0.00145	0.00149	CcSEcCtD
Lubiprostone—Hyperhidrosis—Pamidronate—osteoporosis	0.00145	0.00148	CcSEcCtD
Lubiprostone—Syncope—Conjugated Estrogens—osteoporosis	0.00145	0.00148	CcSEcCtD
Lubiprostone—Hypersensitivity—Alendronate—osteoporosis	0.00145	0.00148	CcSEcCtD
Lubiprostone—Headache—Etidronic acid—osteoporosis	0.00144	0.00148	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00143	0.00147	CcSEcCtD
Lubiprostone—Asthenia—Estropipate—osteoporosis	0.00143	0.00147	CcSEcCtD
Lubiprostone—Anorexia—Pamidronate—osteoporosis	0.00143	0.00146	CcSEcCtD
Lubiprostone—Chest pain—Zoledronate—osteoporosis	0.00143	0.00146	CcSEcCtD
Lubiprostone—Myalgia—Zoledronate—osteoporosis	0.00143	0.00146	CcSEcCtD
Lubiprostone—Palpitations—Conjugated Estrogens—osteoporosis	0.00143	0.00146	CcSEcCtD
Lubiprostone—Anxiety—Zoledronate—osteoporosis	0.00142	0.00146	CcSEcCtD
Lubiprostone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00142	0.00145	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00142	0.00145	CcSEcCtD
Lubiprostone—Discomfort—Zoledronate—osteoporosis	0.00141	0.00145	CcSEcCtD
Lubiprostone—Asthenia—Alendronate—osteoporosis	0.00141	0.00144	CcSEcCtD
Lubiprostone—Hypersensitivity—Ibandronate—osteoporosis	0.00141	0.00144	CcSEcCtD
Lubiprostone—Cough—Conjugated Estrogens—osteoporosis	0.00141	0.00144	CcSEcCtD
Lubiprostone—Dyspnoea—Risedronate—osteoporosis	0.0014	0.00144	CcSEcCtD
Lubiprostone—Dry mouth—Zoledronate—osteoporosis	0.00139	0.00143	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00139	0.00143	CcSEcCtD
Lubiprostone—Fatigue—Ethinyl Estradiol—osteoporosis	0.00139	0.00143	CcSEcCtD
Lubiprostone—Dyspepsia—Risedronate—osteoporosis	0.00139	0.00142	CcSEcCtD
Lubiprostone—Constipation—Ethinyl Estradiol—osteoporosis	0.00138	0.00142	CcSEcCtD
Lubiprostone—Hypersensitivity—Calcitriol—osteoporosis	0.00138	0.00141	CcSEcCtD
Lubiprostone—Chest pain—Conjugated Estrogens—osteoporosis	0.00137	0.00141	CcSEcCtD
Lubiprostone—Myalgia—Conjugated Estrogens—osteoporosis	0.00137	0.00141	CcSEcCtD
Lubiprostone—Asthenia—Ibandronate—osteoporosis	0.00137	0.00141	CcSEcCtD
Lubiprostone—Anxiety—Conjugated Estrogens—osteoporosis	0.00137	0.0014	CcSEcCtD
Lubiprostone—Nausea—Etidronic acid—osteoporosis	0.00137	0.0014	CcSEcCtD
Lubiprostone—Oedema—Zoledronate—osteoporosis	0.00137	0.0014	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00136	0.0014	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00136	0.0014	CcSEcCtD
Lubiprostone—Diarrhoea—Estropipate—osteoporosis	0.00136	0.0014	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Risedronate—osteoporosis	0.00136	0.00139	CcSEcCtD
Lubiprostone—Fatigue—Risedronate—osteoporosis	0.00136	0.00139	CcSEcCtD
Lubiprostone—Constipation—Risedronate—osteoporosis	0.00135	0.00138	CcSEcCtD
Lubiprostone—Pain—Risedronate—osteoporosis	0.00135	0.00138	CcSEcCtD
Lubiprostone—Shock—Zoledronate—osteoporosis	0.00135	0.00138	CcSEcCtD
Lubiprostone—Diarrhoea—Alendronate—osteoporosis	0.00134	0.00138	CcSEcCtD
Lubiprostone—Asthenia—Calcitriol—osteoporosis	0.00134	0.00138	CcSEcCtD
Lubiprostone—Nervous system disorder—Zoledronate—osteoporosis	0.00134	0.00138	CcSEcCtD
Lubiprostone—Mediastinal disorder—Estradiol—osteoporosis	0.00134	0.00137	CcSEcCtD
Lubiprostone—Dyspnoea—Pamidronate—osteoporosis	0.00133	0.00137	CcSEcCtD
Lubiprostone—Tachycardia—Zoledronate—osteoporosis	0.00133	0.00137	CcSEcCtD
Lubiprostone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00133	0.00137	CcSEcCtD
Lubiprostone—Skin disorder—Zoledronate—osteoporosis	0.00133	0.00136	CcSEcCtD
Lubiprostone—Hyperhidrosis—Zoledronate—osteoporosis	0.00132	0.00136	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00132	0.00135	CcSEcCtD
Lubiprostone—Diarrhoea—Raloxifene—osteoporosis	0.00132	0.00135	CcSEcCtD
Lubiprostone—Dyspepsia—Pamidronate—osteoporosis	0.00132	0.00135	CcSEcCtD
Lubiprostone—Dizziness—Estropipate—osteoporosis	0.00132	0.00135	CcSEcCtD
Lubiprostone—Oedema—Conjugated Estrogens—osteoporosis	0.00132	0.00135	CcSEcCtD
Lubiprostone—Diarrhoea—Ibandronate—osteoporosis	0.00131	0.00134	CcSEcCtD
Lubiprostone—Anorexia—Zoledronate—osteoporosis	0.0013	0.00134	CcSEcCtD
Lubiprostone—Decreased appetite—Pamidronate—osteoporosis	0.0013	0.00133	CcSEcCtD
Lubiprostone—Mental disorder—Estradiol—osteoporosis	0.0013	0.00133	CcSEcCtD
Lubiprostone—Dizziness—Alendronate—osteoporosis	0.0013	0.00133	CcSEcCtD
Lubiprostone—Shock—Conjugated Estrogens—osteoporosis	0.0013	0.00133	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00129	0.00133	CcSEcCtD
Lubiprostone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00129	0.00132	CcSEcCtD
Lubiprostone—Erythema—Estradiol—osteoporosis	0.00129	0.00132	CcSEcCtD
Lubiprostone—Malnutrition—Estradiol—osteoporosis	0.00129	0.00132	CcSEcCtD
Lubiprostone—Fatigue—Pamidronate—osteoporosis	0.00129	0.00132	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Risedronate—osteoporosis	0.00129	0.00132	CcSEcCtD
Lubiprostone—Tachycardia—Conjugated Estrogens—osteoporosis	0.00128	0.00132	CcSEcCtD
Lubiprostone—Pain—Pamidronate—osteoporosis	0.00128	0.00131	CcSEcCtD
Lubiprostone—Constipation—Pamidronate—osteoporosis	0.00128	0.00131	CcSEcCtD
Lubiprostone—Diarrhoea—Calcitriol—osteoporosis	0.00128	0.00131	CcSEcCtD
Lubiprostone—Skin disorder—Conjugated Estrogens—osteoporosis	0.00128	0.00131	CcSEcCtD
Lubiprostone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00128	0.00131	CcSEcCtD
Lubiprostone—Dizziness—Raloxifene—osteoporosis	0.00128	0.00131	CcSEcCtD
Lubiprostone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00127	0.00131	CcSEcCtD
Lubiprostone—Flatulence—Estradiol—osteoporosis	0.00127	0.00131	CcSEcCtD
Lubiprostone—Vomiting—Estropipate—osteoporosis	0.00127	0.0013	CcSEcCtD
Lubiprostone—Dysgeusia—Estradiol—osteoporosis	0.00126	0.0013	CcSEcCtD
Lubiprostone—Dizziness—Ibandronate—osteoporosis	0.00126	0.0013	CcSEcCtD
Lubiprostone—Rash—Estropipate—osteoporosis	0.00126	0.00129	CcSEcCtD
Lubiprostone—Dermatitis—Estropipate—osteoporosis	0.00126	0.00129	CcSEcCtD
Lubiprostone—Anorexia—Conjugated Estrogens—osteoporosis	0.00125	0.00129	CcSEcCtD
Lubiprostone—Headache—Estropipate—osteoporosis	0.00125	0.00128	CcSEcCtD
Lubiprostone—Vomiting—Alendronate—osteoporosis	0.00125	0.00128	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00125	0.00128	CcSEcCtD
Lubiprostone—Abdominal pain—Risedronate—osteoporosis	0.00124	0.00128	CcSEcCtD
Lubiprostone—Muscle spasms—Estradiol—osteoporosis	0.00124	0.00127	CcSEcCtD
Lubiprostone—Rash—Alendronate—osteoporosis	0.00124	0.00127	CcSEcCtD
Lubiprostone—Dermatitis—Alendronate—osteoporosis	0.00124	0.00127	CcSEcCtD
Lubiprostone—Feeling abnormal—Pamidronate—osteoporosis	0.00123	0.00127	CcSEcCtD
Lubiprostone—Headache—Alendronate—osteoporosis	0.00123	0.00126	CcSEcCtD
Lubiprostone—Vomiting—Raloxifene—osteoporosis	0.00123	0.00126	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Pamidronate—osteoporosis	0.00122	0.00126	CcSEcCtD
Lubiprostone—Dyspnoea—Zoledronate—osteoporosis	0.00122	0.00125	CcSEcCtD
Lubiprostone—Rash—Raloxifene—osteoporosis	0.00122	0.00125	CcSEcCtD
Lubiprostone—Dermatitis—Raloxifene—osteoporosis	0.00122	0.00125	CcSEcCtD
Lubiprostone—Vomiting—Ibandronate—osteoporosis	0.00121	0.00125	CcSEcCtD
Lubiprostone—Tremor—Estradiol—osteoporosis	0.00121	0.00124	CcSEcCtD
Lubiprostone—Headache—Raloxifene—osteoporosis	0.00121	0.00124	CcSEcCtD
Lubiprostone—Rash—Ibandronate—osteoporosis	0.0012	0.00124	CcSEcCtD
Lubiprostone—Dermatitis—Ibandronate—osteoporosis	0.0012	0.00123	CcSEcCtD
Lubiprostone—Dyspepsia—Zoledronate—osteoporosis	0.0012	0.00123	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.0012	0.00123	CcSEcCtD
Lubiprostone—Ill-defined disorder—Estradiol—osteoporosis	0.0012	0.00123	CcSEcCtD
Lubiprostone—Headache—Ibandronate—osteoporosis	0.0012	0.00123	CcSEcCtD
Lubiprostone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00119	0.00122	CcSEcCtD
Lubiprostone—Vomiting—Calcitriol—osteoporosis	0.00119	0.00122	CcSEcCtD
Lubiprostone—Decreased appetite—Zoledronate—osteoporosis	0.00119	0.00122	CcSEcCtD
Lubiprostone—Nausea—Estropipate—osteoporosis	0.00118	0.00121	CcSEcCtD
Lubiprostone—Abdominal pain—Pamidronate—osteoporosis	0.00118	0.00121	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00118	0.00121	CcSEcCtD
Lubiprostone—Rash—Calcitriol—osteoporosis	0.00118	0.00121	CcSEcCtD
Lubiprostone—Fatigue—Zoledronate—osteoporosis	0.00118	0.00121	CcSEcCtD
Lubiprostone—Dermatitis—Calcitriol—osteoporosis	0.00118	0.00121	CcSEcCtD
Lubiprostone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00117	0.0012	CcSEcCtD
Lubiprostone—Headache—Calcitriol—osteoporosis	0.00117	0.0012	CcSEcCtD
Lubiprostone—Constipation—Zoledronate—osteoporosis	0.00117	0.0012	CcSEcCtD
Lubiprostone—Pain—Zoledronate—osteoporosis	0.00117	0.0012	CcSEcCtD
Lubiprostone—Nausea—Alendronate—osteoporosis	0.00117	0.0012	CcSEcCtD
Lubiprostone—Malaise—Estradiol—osteoporosis	0.00116	0.00119	CcSEcCtD
Lubiprostone—Hypersensitivity—Risedronate—osteoporosis	0.00116	0.00119	CcSEcCtD
Lubiprostone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00116	0.00119	CcSEcCtD
Lubiprostone—Asthenia—Ethinyl Estradiol—osteoporosis	0.00116	0.00119	CcSEcCtD
Lubiprostone—Syncope—Estradiol—osteoporosis	0.00116	0.00119	CcSEcCtD
Lubiprostone—Nausea—Raloxifene—osteoporosis	0.00115	0.00118	CcSEcCtD
Lubiprostone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00114	0.00117	CcSEcCtD
Lubiprostone—Palpitations—Estradiol—osteoporosis	0.00114	0.00117	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00114	0.00117	CcSEcCtD
Lubiprostone—Fatigue—Conjugated Estrogens—osteoporosis	0.00114	0.00116	CcSEcCtD
Lubiprostone—Nausea—Ibandronate—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Loss of consciousness—Estradiol—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Asthenia—Risedronate—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Feeling abnormal—Zoledronate—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Cough—Estradiol—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Pain—Conjugated Estrogens—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Constipation—Conjugated Estrogens—osteoporosis	0.00113	0.00116	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Zoledronate—osteoporosis	0.00112	0.00115	CcSEcCtD
Lubiprostone—Nausea—Calcitriol—osteoporosis	0.00111	0.00114	CcSEcCtD
Lubiprostone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.0011	0.00113	CcSEcCtD
Lubiprostone—Hypersensitivity—Pamidronate—osteoporosis	0.0011	0.00113	CcSEcCtD
Lubiprostone—Myalgia—Estradiol—osteoporosis	0.0011	0.00113	CcSEcCtD
Lubiprostone—Chest pain—Estradiol—osteoporosis	0.0011	0.00113	CcSEcCtD
Lubiprostone—Anxiety—Estradiol—osteoporosis	0.0011	0.00112	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00109	0.00112	CcSEcCtD
Lubiprostone—Discomfort—Estradiol—osteoporosis	0.00109	0.00111	CcSEcCtD
Lubiprostone—Abdominal pain—Zoledronate—osteoporosis	0.00108	0.00111	CcSEcCtD
Lubiprostone—Diarrhoea—Risedronate—osteoporosis	0.00108	0.00111	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00108	0.0011	CcSEcCtD
Lubiprostone—Dry mouth—Estradiol—osteoporosis	0.00107	0.0011	CcSEcCtD
Lubiprostone—Asthenia—Pamidronate—osteoporosis	0.00107	0.0011	CcSEcCtD
Lubiprostone—Dizziness—Ethinyl Estradiol—osteoporosis	0.00107	0.0011	CcSEcCtD
Lubiprostone—Oedema—Estradiol—osteoporosis	0.00105	0.00108	CcSEcCtD
Lubiprostone—Dizziness—Risedronate—osteoporosis	0.00104	0.00107	CcSEcCtD
Lubiprostone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00104	0.00107	CcSEcCtD
Lubiprostone—Shock—Estradiol—osteoporosis	0.00104	0.00106	CcSEcCtD
Lubiprostone—Nervous system disorder—Estradiol—osteoporosis	0.00103	0.00106	CcSEcCtD
Lubiprostone—Tachycardia—Estradiol—osteoporosis	0.00103	0.00106	CcSEcCtD
Lubiprostone—Vomiting—Ethinyl Estradiol—osteoporosis	0.00103	0.00105	CcSEcCtD
Lubiprostone—Diarrhoea—Pamidronate—osteoporosis	0.00102	0.00105	CcSEcCtD
Lubiprostone—Skin disorder—Estradiol—osteoporosis	0.00102	0.00105	CcSEcCtD
Lubiprostone—Hyperhidrosis—Estradiol—osteoporosis	0.00102	0.00105	CcSEcCtD
Lubiprostone—Rash—Ethinyl Estradiol—osteoporosis	0.00102	0.00104	CcSEcCtD
Lubiprostone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00102	0.00104	CcSEcCtD
Lubiprostone—Headache—Ethinyl Estradiol—osteoporosis	0.00101	0.00104	CcSEcCtD
Lubiprostone—Hypersensitivity—Zoledronate—osteoporosis	0.00101	0.00103	CcSEcCtD
Lubiprostone—Vomiting—Risedronate—osteoporosis	0.001	0.00103	CcSEcCtD
Lubiprostone—Rash—Risedronate—osteoporosis	0.000993	0.00102	CcSEcCtD
Lubiprostone—Dermatitis—Risedronate—osteoporosis	0.000992	0.00102	CcSEcCtD
Lubiprostone—Dizziness—Pamidronate—osteoporosis	0.00099	0.00102	CcSEcCtD
Lubiprostone—Headache—Risedronate—osteoporosis	0.000986	0.00101	CcSEcCtD
Lubiprostone—Asthenia—Zoledronate—osteoporosis	0.000981	0.00101	CcSEcCtD
Lubiprostone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00097	0.000995	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00096	0.000985	CcSEcCtD
Lubiprostone—Nausea—Ethinyl Estradiol—osteoporosis	0.000959	0.000984	CcSEcCtD
Lubiprostone—Vomiting—Pamidronate—osteoporosis	0.000952	0.000976	CcSEcCtD
Lubiprostone—Asthenia—Conjugated Estrogens—osteoporosis	0.000945	0.000969	CcSEcCtD
Lubiprostone—Rash—Pamidronate—osteoporosis	0.000944	0.000968	CcSEcCtD
Lubiprostone—Dermatitis—Pamidronate—osteoporosis	0.000943	0.000967	CcSEcCtD
Lubiprostone—Dyspnoea—Estradiol—osteoporosis	0.000939	0.000964	CcSEcCtD
Lubiprostone—Headache—Pamidronate—osteoporosis	0.000938	0.000962	CcSEcCtD
Lubiprostone—Diarrhoea—Zoledronate—osteoporosis	0.000935	0.00096	CcSEcCtD
Lubiprostone—Nausea—Risedronate—osteoporosis	0.000935	0.00096	CcSEcCtD
Lubiprostone—Dyspepsia—Estradiol—osteoporosis	0.000927	0.000952	CcSEcCtD
Lubiprostone—Decreased appetite—Estradiol—osteoporosis	0.000916	0.00094	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Estradiol—osteoporosis	0.00091	0.000933	CcSEcCtD
Lubiprostone—Fatigue—Estradiol—osteoporosis	0.000908	0.000932	CcSEcCtD
Lubiprostone—Dizziness—Zoledronate—osteoporosis	0.000904	0.000928	CcSEcCtD
Lubiprostone—Pain—Estradiol—osteoporosis	0.000901	0.000924	CcSEcCtD
Lubiprostone—Constipation—Estradiol—osteoporosis	0.000901	0.000924	CcSEcCtD
Lubiprostone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000901	0.000924	CcSEcCtD
Lubiprostone—Nausea—Pamidronate—osteoporosis	0.000889	0.000912	CcSEcCtD
Lubiprostone—Dizziness—Conjugated Estrogens—osteoporosis	0.000871	0.000893	CcSEcCtD
Lubiprostone—Vomiting—Zoledronate—osteoporosis	0.000869	0.000892	CcSEcCtD
Lubiprostone—Feeling abnormal—Estradiol—osteoporosis	0.000868	0.000891	CcSEcCtD
Lubiprostone—Rash—Zoledronate—osteoporosis	0.000862	0.000884	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Estradiol—osteoporosis	0.000862	0.000884	CcSEcCtD
Lubiprostone—Dermatitis—Zoledronate—osteoporosis	0.000861	0.000884	CcSEcCtD
Lubiprostone—Headache—Zoledronate—osteoporosis	0.000857	0.000879	CcSEcCtD
Lubiprostone—Vomiting—Conjugated Estrogens—osteoporosis	0.000837	0.000859	CcSEcCtD
Lubiprostone—Abdominal pain—Estradiol—osteoporosis	0.000833	0.000855	CcSEcCtD
Lubiprostone—Rash—Conjugated Estrogens—osteoporosis	0.00083	0.000852	CcSEcCtD
Lubiprostone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000829	0.000851	CcSEcCtD
Lubiprostone—Headache—Conjugated Estrogens—osteoporosis	0.000825	0.000846	CcSEcCtD
Lubiprostone—Nausea—Zoledronate—osteoporosis	0.000812	0.000833	CcSEcCtD
Lubiprostone—Nausea—Conjugated Estrogens—osteoporosis	0.000782	0.000802	CcSEcCtD
Lubiprostone—Hypersensitivity—Estradiol—osteoporosis	0.000776	0.000796	CcSEcCtD
Lubiprostone—Asthenia—Estradiol—osteoporosis	0.000756	0.000776	CcSEcCtD
Lubiprostone—Diarrhoea—Estradiol—osteoporosis	0.000721	0.00074	CcSEcCtD
Lubiprostone—Dizziness—Estradiol—osteoporosis	0.000697	0.000715	CcSEcCtD
Lubiprostone—Vomiting—Estradiol—osteoporosis	0.00067	0.000687	CcSEcCtD
Lubiprostone—Rash—Estradiol—osteoporosis	0.000664	0.000682	CcSEcCtD
Lubiprostone—Dermatitis—Estradiol—osteoporosis	0.000664	0.000681	CcSEcCtD
Lubiprostone—Headache—Estradiol—osteoporosis	0.00066	0.000677	CcSEcCtD
Lubiprostone—Nausea—Estradiol—osteoporosis	0.000626	0.000642	CcSEcCtD
